TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.390
-0.110 (-4.40%)
At close: Sep 15, 2025, 4:00 PM EDT
2.390
0.00 (0.00%)
After-hours: Sep 15, 2025, 5:10 PM EDT

TuHURA Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Net Income
-27.76-21.68-29.32-9.37
Depreciation & Amortization
0.070.120.180.37
Other Amortization
0.841.280.01-
Asset Writedown & Restructuring Costs
--16.22-
Stock-Based Compensation
4.181.960.480.22
Other Operating Activities
-0.020.31--0.29
Change in Accounts Payable
6.313.640.341.85
Change in Other Net Operating Assets
-0.44-0.360.15-0.29
Operating Cash Flow
-16.81-14.73-11.95-7.51
Capital Expenditures
-0.07-0.06-1.3-0.04
Cash Acquisitions
-7.25-5.99--
Investing Cash Flow
-7.32-6.05-1.3-0.04
Long-Term Debt Issued
-28.572.69-
Long-Term Debt Repaid
--0.8--0.35
Net Debt Issued (Repaid)
8.727.772.69-0.35
Issuance of Common Stock
16.587.05--
Repurchase of Common Stock
---0.02-
Other Financing Activities
-4.94-5.05--
Financing Cash Flow
20.3429.772.6616.25
Net Cash Flow
-3.88.99-10.598.71
Free Cash Flow
-16.88-14.79-13.25-7.54
Free Cash Flow Per Share
-0.48-0.79-1.11-
Levered Free Cash Flow
--15.19-8.29-
Unlevered Free Cash Flow
--13.88-8.29-
Change in Working Capital
5.873.290.491.56
Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q